IL174396A - Oral drug delivery system - Google Patents

Oral drug delivery system

Info

Publication number
IL174396A
IL174396A IL174396A IL17439606A IL174396A IL 174396 A IL174396 A IL 174396A IL 174396 A IL174396 A IL 174396A IL 17439606 A IL17439606 A IL 17439606A IL 174396 A IL174396 A IL 174396A
Authority
IL
Israel
Prior art keywords
coating
composition
drug delivery
delivery system
active ingredient
Prior art date
Application number
IL174396A
Other languages
English (en)
Other versions
IL174396A0 (en
Inventor
Nitin Bhalachandra Dharmadhikari
Yashoraj Rupsinh Zala
Amarjit Singh
Original Assignee
Sun Pharmaceutical Ind Ltd
Nitin Bhalachandra Dharmadhikari
Yashoraj Rupsinh Zala
Amarjit Singh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34509346&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL174396(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sun Pharmaceutical Ind Ltd, Nitin Bhalachandra Dharmadhikari, Yashoraj Rupsinh Zala, Amarjit Singh filed Critical Sun Pharmaceutical Ind Ltd
Publication of IL174396A0 publication Critical patent/IL174396A0/en
Publication of IL174396A publication Critical patent/IL174396A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL174396A 2003-09-19 2006-03-19 Oral drug delivery system IL174396A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN987MU2003 2003-09-19
PCT/IN2004/000192 WO2005039481A2 (en) 2003-09-19 2004-06-30 Oral drug delivery system

Publications (2)

Publication Number Publication Date
IL174396A0 IL174396A0 (en) 2006-08-01
IL174396A true IL174396A (en) 2012-02-29

Family

ID=34509346

Family Applications (1)

Application Number Title Priority Date Filing Date
IL174396A IL174396A (en) 2003-09-19 2006-03-19 Oral drug delivery system

Country Status (17)

Country Link
US (2) US8163306B2 (enExample)
EP (1) EP1663175B1 (enExample)
JP (2) JP5666075B2 (enExample)
KR (1) KR101164881B1 (enExample)
CN (1) CN1856299B (enExample)
AP (1) AP2006003602A0 (enExample)
AT (1) ATE551051T1 (enExample)
AU (2) AU2004283565C1 (enExample)
BR (1) BRPI0414305A (enExample)
CA (1) CA2543353C (enExample)
EA (1) EA013106B1 (enExample)
IL (1) IL174396A (enExample)
NZ (1) NZ546543A (enExample)
PL (2) PL381756A1 (enExample)
UA (1) UA85850C2 (enExample)
WO (1) WO2005039481A2 (enExample)
ZA (1) ZA200602276B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03008997A (es) * 2001-04-10 2004-02-12 Sun Pharmaceutical Ind Ltd Composicion de liberacion por impulso temporizado.
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
AP2006003602A0 (en) * 2003-09-19 2006-04-30 Sun Pharmaceutical Ind Ltd Oral drug delivery system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US8431156B2 (en) * 2005-02-22 2013-04-30 Sun Pharma Advanced Research Company Ltd. Pharmaceutical composition
CN101146521A (zh) * 2005-03-14 2008-03-19 太阳医药高级研究有限公司 提供包含纤维素和甲基丙烯酸衍生物包衣的口服药物输送系统
US8920837B2 (en) 2005-07-01 2014-12-30 Rubicon Research Private Limited Sustained release dosage form
EP1945189A4 (en) * 2005-11-03 2012-08-15 Sun Pharmaceutical Ind Ltd CONTROLLED RELEASE COATED TABLETS CHARACTERIZED BY PROLONGED GASTRIC RETENTION
WO2009087663A2 (en) * 2007-11-30 2009-07-16 Sun Pharmaceutical Industries Ltd. Oral controlled release coated tablet
CA2715584A1 (en) * 2008-02-15 2009-10-08 Sun Pharma Advanced Research Company Ltd. Oral controlled release tablet
KR20140069381A (ko) * 2009-06-02 2014-06-10 다우 글로벌 테크놀로지스 엘엘씨 서방출 투여형
US10485770B2 (en) * 2009-12-21 2019-11-26 Aptapharma, Inc. Functionally-coated multilayer tablets
FR2985177B1 (fr) * 2012-01-02 2016-04-01 Oreal Composition cosmetique solide aqueuse comprenant de l'alkylcellulose, au moins deux huiles non volatiles et au moins deux agents tensioactifs
FR2985179B1 (fr) * 2012-01-02 2020-05-15 L'oreal Composition cosmetique aqueuse solide comprenant de l'alkylcellulose, au moins deux huiles non volatiles et au moins deux agents tensioactifs
JP5941117B2 (ja) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
EP3600320A4 (en) 2017-03-31 2020-12-16 Acura Pharmaceuticals, Inc. METHODS AND COMPOSITIONS FOR THE SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL SUBSTANCES
IT201800011123A1 (it) * 2018-12-14 2020-06-14 Dpl Pharma S P A Composizioni farmaceutiche orali solide per la somministrazione cronotropica di sartani
CA3187551A1 (en) * 2020-07-28 2022-02-03 Fang Zhou Novel gastroretentive extended release dosage form

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2140687A (en) * 1938-02-04 1938-12-20 Claude W Mcqueen Tractor drive take-off
NZ206600A (en) 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
US4693896A (en) 1985-10-07 1987-09-15 Fmc Corporation Ethylcellulose-coated, gastric-disintegrable aspirin tablet
IT1188212B (it) 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
US5271946A (en) * 1988-04-20 1993-12-21 Asta Pharma Aktiengesellschaft Controlled release azelastine-containing pharmaceutical compositions
IT1237904B (it) 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
DE69229881T2 (de) * 1991-10-04 1999-12-09 Yoshitomi Pharmaceutical Industries, Ltd. Tablette mit verzögerter freisetzung
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
ATE128363T1 (de) 1993-05-15 1995-10-15 Boehringer Mannheim Gmbh Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff.
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US20010055613A1 (en) * 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
JP2001055322A (ja) * 1999-08-18 2001-02-27 Tanabe Seiyaku Co Ltd パルス放出型製剤
US6332819B1 (en) * 1999-10-08 2001-12-25 Jerrold K. Emmons Object retrieval device used in water
US6720005B1 (en) 2000-07-07 2004-04-13 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Coated, platform-generating tablet
EA005537B1 (ru) 2001-07-10 2005-04-28 Тева Фармасьютикал Индастриес Лтд. Система доставки лекарственного вещества по нулевому порядку, нулевому порядку - двухстадийной, возрастающей или убывающей доставки препарата
ITMI20020514A1 (it) 2002-03-12 2003-09-12 Jagotec Ag Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
ITMI20020515A1 (it) 2002-03-12 2003-09-12 Jagotec Ag Sistema per il rilasco controllato di uno o piu' principi attivi
WO2004108067A2 (en) 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
AP2006003602A0 (en) 2003-09-19 2006-04-30 Sun Pharmaceutical Ind Ltd Oral drug delivery system

Also Published As

Publication number Publication date
WO2005039481A3 (en) 2005-07-28
BRPI0414305A (pt) 2006-11-07
US8470367B2 (en) 2013-06-25
EA200600603A1 (ru) 2006-08-25
US20070071816A1 (en) 2007-03-29
AU2004283565A1 (en) 2005-05-06
AU2011200881A1 (en) 2011-03-24
JP5666075B2 (ja) 2015-02-12
KR101164881B1 (ko) 2012-07-23
CN1856299B (zh) 2013-09-04
AP2006003602A0 (en) 2006-04-30
CA2543353C (en) 2012-05-15
UA85850C2 (uk) 2009-03-10
JP2015038126A (ja) 2015-02-26
AU2004283565C1 (en) 2011-10-27
CA2543353A1 (en) 2005-05-06
KR20060076307A (ko) 2006-07-04
NZ546543A (en) 2010-07-30
IL174396A0 (en) 2006-08-01
US8163306B2 (en) 2012-04-24
ATE551051T1 (de) 2012-04-15
JP2007505894A (ja) 2007-03-15
CN1856299A (zh) 2006-11-01
EP1663175A2 (en) 2006-06-07
WO2005039481A2 (en) 2005-05-06
PL1663175T3 (pl) 2012-09-28
AU2004283565B2 (en) 2011-03-17
PL381756A1 (pl) 2007-07-09
ZA200602276B (en) 2007-05-30
EA013106B1 (ru) 2010-02-26
EP1663175B1 (en) 2012-03-28
US20080138410A1 (en) 2008-06-12

Similar Documents

Publication Publication Date Title
US8470367B2 (en) Oral drug delivery system
US8535717B2 (en) Pharmaceutical composition
US20090208572A1 (en) Oral controlled release tablet
CA2601800C (en) Oral drug delivery system
US10226428B2 (en) Oral drug delivery system
US10213387B2 (en) Oral drug delivery system
ES2382551T3 (es) Sistema de administración de fármacos orales
MXPA06002994A (en) Oral drug delivery system
HK1092718A (en) Oral drug delivery system

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees